Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9V41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,610
Award facts
- Contract value 100% obligated
- $23,609.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,609.73 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) on January 7, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by January 8, 2026. The award supports pharmaceutical procurement for federal medical supply needs, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving the federal government across multiple therapeutic domains including neurological treatments, diabetes medications, pain management, and specialized medical supplies.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. The parent IDC enables the contractor to supply a vast range of brand-name and generic medications, vaccines, specialty drugs, and medical commodities to support Defense Health Agency facilities, the U.S. Coast Guard, and other federal healthcare systems. The current delivery order exemplifies the company's ongoing role as a critical prime vendor in the federal pharmaceutical supply chain, delivering prescription medications to government medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9V41?
SPE2DR26F9V41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9V41 worth?
The government has obligated $23,610 on SPE2DR26F9V41.
Is contract SPE2DR26F9V41 an order under another contract?
Yes. SPE2DR26F9V41 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V41 competed?
The extent of competition for SPE2DR26F9V41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award